Xcout Intel
NurExone Biologic Inc. competitors & alternatives
The 12 closest competitors and alternatives to NurExone Biologic Inc. among biotech companies — ranked by similarity to what NurExone Biologic Inc. actually does, not by market-cap band.
Subscribe to see NurExone Biologic Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About NurExone Biologic Inc.
NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. Its lead product, ExoPTEN, has demonstrated strong preclinical data supporting clinical potential in treating acute spinal cord and optic nerve injury. The company was founded on June 27, 2011 and is headquartered in Toronto, Canada.
NurExone Biologic Inc. at a glance
NurExone Biologic Inc. is a biotech company headquartered in Toronto, Canada. It is publicly listed (NRX) with a market capitalisation of $23.3M. Xcout tracks 11 named people at NurExone Biologic Inc., including Eran Ovadya (Chief Financial Officer).
NurExone Biologic Inc. leadership
- Eran OvadyaChief Financial Officer
- Yoram DruckerChairman of the Board
- Eran OvadyaExecutive Officer
- Lior ShaltielExecutive Officer
- Yoram DruckerExecutive Officer
- Eyal GabbaiDirector
5 more named people on record for NurExone Biologic Inc., with roles, board committees and tenure — see the full roster →
Top 12 NurExone Biologic Inc. competitors
Ranked by semantic similarity — how close each company is to NurExone Biologic Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
DCx Biotherapeutics is a Canadian preclinical-stage biotechnology company developing precision oncology therapeutics and precision drug conjugates to target genetically defined cancers. The company focuses on addressing root drivers and key cellular interdependencies of cancer lesions.
Life Sciences
OncXerna Therapeutics is a clinical-stage precision-oncology biotechnology company that develops RNA-based biomarkers and targeted cancer therapies. Its work is intended to help identify cancer patients most likely to benefit from particular treatments and support oncologists and pharmaceutical partners in treatment selection.
Similar biotech company
Aptose Biosciences Inc. is a clinical-stage biotechnology company that develops small molecule cancer therapeutics, focusing on precision medicines for hematologic malignancies. The company's product pipeline features investigational drug candidates such as tuspetinib and luxeptinib, which are designed to treat conditions like acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and B-cell malignancies.
Similar biotech company
NanoVation Therapeutics is a platform developer headquartered in Vancouver, British Columbia, that partners with leading pharmaceutical and biotech companies to enable genetic medicines.
Similar biotech company
Neumora Therapeutics is a clinical-stage biopharmaceutical company developing precision medicines for brain diseases, including neuropsychiatric and neurodegenerative disorders. It uses neuroscience, data science, and biomarkers to identify and advance treatments for patients with these conditions.
Similar biotech company
Verge Genomics develops a proprietary AI and machine learning platform utilizing human brain data to transform neuroscience drug discovery and precision neurology. The company provides foundation models and analytical tools to pharmaceutical and biotechnology developers for target discovery, biomarker identification, and clinical trial patient stratification.
Biotechnology
Nido Biosciences, Inc. is a clinical-stage holding and biotechnology company headquartered in Watertown, Massachusetts. The company focuses on discovering and advancing treatments for debilitating neurological diseases, including the development of targeted drugs.
Biotechnology
Navion Neurosciences, Inc. is a preclinical-stage biotechnology company located in Charlottesville, Virginia, that is developing next-generation, AI-enabled therapies.
Biotechnology
Neuron23 is a biotechnology company founded in 2018 that focuses on developing precision therapeutics for genetic diseases. Headquartered in South San Francisco, California, the company relies on a team of scientific experts and entrepreneurs.
Biotechnology
NutrigeneAI Biotech Limited is an iPSC cell therapy platform operating in Hong Kong. The company focuses on biotechnology research and development, maintaining pipeline therapies and regional office operations.
Biotechnology
Canary Cure Therapeutics is a privately held biopharmaceutical company headquartered in Burlington, Canada. It focuses on developing novel gene and RNA therapies to address various medical needs. The company operates with a small team and maintains its primary operations in Ontario.
Pharmaceuticals
Damona Pharmaceuticals is a biotechnology research company developing microcircuit precision medicines aimed at restoring cognitive functions across various brain disorders. The company is located in Toronto, Ontario.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of NurExone Biologic Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for NurExone Biologic Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →